220 related articles for article (PubMed ID: 32030410)
1. The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity.
Tansley SL; Li D; Betteridge ZE; McHugh NJ
Rheumatology (Oxford); 2020 Aug; 59(8):2109-2114. PubMed ID: 32030410
[TBL] [Abstract][Full Text] [Related]
2. Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.
Cavazzana I; Fredi M; Ceribelli A; Mordenti C; Ferrari F; Carabellese N; Tincani A; Satoh M; Franceschini F
J Immunol Methods; 2016 Jun; 433():1-5. PubMed ID: 26906088
[TBL] [Abstract][Full Text] [Related]
3. A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing.
Mulhearn B; Li D; McMorrow F; Lu H; McHugh NJ; Tansley SL
Front Immunol; 2022; 13():804037. PubMed ID: 35154119
[TBL] [Abstract][Full Text] [Related]
4. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
5. The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis.
Tansley SL; Snowball J; Pauling JD; Lissina A; Kuwana M; Rider LG; Rönnelid J; McHugh NJ;
Arthritis Res Ther; 2020 May; 22(1):117. PubMed ID: 32414409
[TBL] [Abstract][Full Text] [Related]
6. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
Rheumatology (Oxford); 2015 Jul; 54(7):1194-9. PubMed ID: 25524922
[TBL] [Abstract][Full Text] [Related]
7. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort.
Loganathan A; Gupta L; Rudge A; Lu H; Bowler E; McMorrow F; Naveen R; Anuja AK; Agarwal V; McHugh N; Tansley S
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38479813
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
[TBL] [Abstract][Full Text] [Related]
9. Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation.
Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
Rheumatology (Oxford); 2014 Mar; 53(3):433-7. PubMed ID: 24255164
[TBL] [Abstract][Full Text] [Related]
10. A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.
Tampoia M; Notarnicola A; Abbracciavento L; Fontana A; Giannini M; Louis Humbel R; Iannone F
J Clin Lab Anal; 2016 Nov; 30(6):859-866. PubMed ID: 27074881
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
Koenig M; Fritzler MJ; Targoff IN; Troyanov Y; Senécal JL
Arthritis Res Ther; 2007; 9(4):R78. PubMed ID: 17688695
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies.
Mahler M; Betteridge Z; Bentow C; Richards M; Seaman A; Chinoy H; McHugh N
Front Immunol; 2019; 10():848. PubMed ID: 31114570
[No Abstract] [Full Text] [Related]
13. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.
Loganathan A; Zanframundo G; Yoshida A; Faghihi-Kashani S; Bauer Ventura I; Dourado E; Bozan F; Sambataro G; Yamano Y; Bae SS; Lim D; Ceribelli A; Isailovic N; Selmi C; Fertig N; Bravi E; Kaneko Y; Saraiva AP; Jovani V; Bachiller-Corral J; Cifrian J; Mera-Varela A; Moghadam-Kia S; Wolff V; Campagne J; Meyer A; Giannini M; Triantafyllias K; Knitza J; Gupta L; Molad Y; Iannone F; Cavazzana I; Piga M; De Luca G; Tansley S; Bozzalla-Cassione E; Bonella F; Corte TJ; Doyle TJ; Fiorentino D; Gonzalez-Gay MA; Hudson M; Kuwana M; Lundberg IE; Mammen AL; McHugh NJ; Miller FW; Montecucco C; Oddis CV; Rojas-Serrano J; Schmidt J; Scirè CA; Selva-O'Callaghan A; Werth VP; Alpini C; Bozzini S; Cavagna L; Aggarwal R;
Clin Exp Rheumatol; 2024 Feb; 42(2):277-287. PubMed ID: 38488094
[TBL] [Abstract][Full Text] [Related]
14. The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population.
Loganathan A; McMorrow F; Lu H; Li D; Mulhearn B; McHugh NJ; Tansley SL
Front Immunol; 2022; 13():975939. PubMed ID: 36177007
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.
Montagnese F; Babačić H; Eichhorn P; Schoser B
J Neurol; 2019 Jun; 266(6):1358-1366. PubMed ID: 30840145
[TBL] [Abstract][Full Text] [Related]
16. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
[TBL] [Abstract][Full Text] [Related]
17. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
Rönnelid J; Barbasso Helmers S; Storfors H; Grip K; Rönnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154
[TBL] [Abstract][Full Text] [Related]
18. Myositis autoantibodies: recent perspectives.
Riddell V; Bagby S; McHugh N
Curr Opin Rheumatol; 2020 Nov; 32(6):548-552. PubMed ID: 32890028
[TBL] [Abstract][Full Text] [Related]
19. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein.
Espada G; Maldonado Cocco JA; Fertig N; Oddis CV
J Rheumatol; 2009 Nov; 36(11):2547-51. PubMed ID: 19833756
[TBL] [Abstract][Full Text] [Related]
20. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.
Frank MB; McCubbin V; Trieu E; Wu Y; Isenberg DA; Targoff IN
J Autoimmun; 1999 Mar; 12(2):137-42. PubMed ID: 10047434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
